Interleukins and other messengers/markers Flashcards
IL-3
HSC differentiation: common myeloid progenitors / with IL-7, B cells
GM-CSF
HSC differentiation: common myeloid progenitors / monocytes/macrophages
IL-7
HSC differentiation: common lymphoid progenitors / with IL-2, T cells / with IL-3, B cells
IL-4
HSC differentiation: basophils
Immune respones: strong activator of BCs and signature cytokine of Th2 response. Inhibits TMMI/Th17
G-CSF
HSC differentiation: neutrophils
IL-5
HSC differentiation: eosinophils
M-CSF
HSC differentiation: Monocytes/macrophages
Flt3L
HSC differentiation: Dendritic cells
IL-2
HSC differentiation: with IL-7, T cells
TMMI: self-sustaining signal produced by Th1’s after antigen binding + IL12/18 - critical growth cytokine
also enhances NK and B cell responses
absolutely required for survival of Tregs (cannot produce their own
C1
Initiator of classical pathway of complement activation. Composed of C1qrs. Q must bind/crosslink 2 Ab Fc regions. r has proteolytic activity on s. s cleaves C4; then C2 when part of the C4b2 complex, creating C4b2a, a C3 convertase
C4
The classical complement pathway protein cleaved by C1s to C4a/b. C4b BINDS TO THE PATHOGEN SURFACE, associates with C2 (cleaved by C1s to C4b2a) to create a C3 convertase
C2
The classical complement pathway protein that associates with membrane bound C4b and is cleaved by C1s to create the C3 convertase, C4b2a
MBL
Mannan-binding lectin. One of two initiators of the lectin pathway of complement activation (compare to C1). Binds directly, with high avidity, to mannose and fucose residues.
MASP-1
mannan binding lectin associated serine protease 1. Compare to C1r; activates MASP-2
MASP-2
mannan binding lectin associated serine protease 2. Compare to C1s; cleaves C4 and, once C4b binds the pathogen and associates with C2, creates C4b2a
C3
Complement pathway protein. C3b binds membrane and acts as a powerful opsonin (rapidly degraded unless it binds a membrane though).
Also complexes with C4b2a to create a C5 convertase. C3a is a soluble inflammatory mediator
C3 also undergoes low levels of spontaneous hydrolysis in serum, at which point it can bind Factor B and allow its cleavage by Factor D to create a C3 convertase. C3bBb3b becomes a C5 convertase
C5
Final common complement pathway protein; cleaved by C5 convertase C4b2a3b OR C3bBb3b. Generation of 5b initiates the final stage of complement activation, formation of the MAC 5a is a soluble inflammatory mediator.
Ficolin
One of two initiators of the lectin pathway of complement initiation. It recognizes acetylated oligosaccharides. It is associated with MASP-1 and 2: compare C1qrs
Factor B
Alternative complement pathway protein. Complexes with C3(H2O) and is hydrolyzed to C3(H2O)Bb to form a C3 convertase.
May also complex with membrane bound C3b, be cleaved by Factor D, then stabilized by properdin to form a membrane bound C3 convertase C3bBb.
Complexes with a second C3b to form a C5 convertase, C3bBb3b.
C6-9
Proteins that participate in forming the MAC in the final common complement pathway (C5b67 complex binds to cell via C7; C8 inserts into membrane; a whole bunch of C9 punches a hole into membrane. Gram-negative only
CR1
AKA CD35
C3b receptors found on phagocytes (esp neutrophils and macrophages) that facilitate phagocytosis of opsonized pathogens. This process is facilitated by C5a.
Also found on erythrocytes allowing for the carrying to and clearance of immune complexes by the spleen and liver.
Can also inhibit C3 convertase, C5 convertase
C5a
soluble inflammatory mediator released when C5 is cleaved by a C5 convertase. Important in recruitment of leukocytes; facilitation of phagocytosis; triggering granule release on mast cells and basophils. This last property makes it (along with 4a and 3a) an anaphylotoxin (and inflammatory mediator)
C4a
Soluble split product of C4. Capable of causing degranulation of mast cells/basophils. Anaphylotoxin and inflammatory mediator
C3a
Soluble split product of C3. Capable of causing degranulation of mast cells/basophils. Anaphylotoxin and inflammatory mediator.
C1INH
C1 Inhibitor. Regulation of complement activation. Inhibits C1 by dissociating C1r and C1s from C1q
DAF
AKA CD55
Decay-accelerating factor. Regulates complement activation by inhibiting (classical) C3 convertase
May be given clinically